Nurix Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Nurix Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 99% to $76,987,000. The net income raised on -$143,948,000 and profit margin reached -187%. Total operating expenses were $232,050,000.
Profit Margin
| 2018 | 37.44M | -9.42M | -25.18% |
|---|---|---|---|
| 2019 | 31.11M | -21.69M | -69.74% |
| 2020 | 17.82M | -43.24M | -242.66% |
| 2021 | 29.75M | -117.19M | -393.93% |
| 2022 | 38.62M | -166.04M | -429.87% |
| 2023 | 76.98M | -143.94M | -186.98% |
NRIX Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 76.98M | 38.62M | 29.75M | 17.82M | 31.11M | 37.44M |
Cost of revenue | 189.14M | 10.80M | 6.08M | 66.49M | 45.02M | 0 |
Gross profit | -112.16M | 27.81M | 23.66M | -48.67M | -13.91M | 37.44M |
Operating exp. | ||||||
Research and development | 189.14M | 184.49M | 116.43M | 66.49M | 45.02M | 40.51M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 232.05M | 222.49M | 147.63M | 82.80M | 53.35M | 47.18M |
Operating income | -155.06M | -183.86M | -117.88M | -64.98M | -22.23M | -9.73M |
Other income (expenses), net | 11.11M | 3.50M | 823K | 1.20M | 776K | 818K |
Income before tax | -143.94M | -180.36M | -117.06M | -63.77M | -21.46M | -8.92M |
Income tax expense | 0 | -14.31M | 131K | -20.53M | 239K | 507K |
Net income | -143.94M | -166.04M | -117.19M | -43.24M | -21.69M | -9.42M |
Earnings per share | ||||||
Basic EPS | -2.65 | -3.42 | -2.73 | -2.76 | -0.56 | -0.59 |
Diluted EPS | -2.65 | -3.42 | -2.73 | -2.76 | -0.56 | -0.59 |
| Data source | Data source | Data source | Data source |